Clinical Genotyping Focus Scisco Genetics specializes in high-resolution immune gene genotyping and offers NGS-based solutions, ASHI/CLIA-certified for clinical labs and transplant programs, indicating strong potential for partnerships with hospitals, transplant centers, and reference laboratories seeking precise HLA and KIR typing services.

NGS Platform Strength The Illumina MiSeq–based platform delivering millions of reads for unambiguous HLA allele typing and KIR haplotyping suggests opportunities to upsell enhanced sequencing services, workflow integration, and scalable data management for mid-size to large clinical labs expanding genotyping capacity.

Integrated Solutions Scisco offers end-to-end solutions including Scisco Services for genotyping, ScisGo Kits for phased 3-field HLA typing, and ScisCloud Software for lab workflow and data management, enabling cross-sell of hardware, consumables, and software subscriptions to streamline operations.

Quality and Compliance ASHI and CLIA certifications signal a commitment to quality and regulatory readiness, which can be leveraged to pursue enterprise customers seeking compliant genotyping workflows, quality control services, and audit-ready data management.

Growth and Accessibility With a lean team and mid-range revenue, Scisco presents an agile partner for collaborative pilot programs, channel partnerships, and sponsored validation studies with academic medical centers and biotechnology firms aiming to expand immune-genotyping capabilities.